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Abstract
Objective—To evaluate inadequate gestational weight gain and fetal growth among overweight
and obese women (O/O).
Study Design—Analysis of prospective singleton term pregnancies in which 1053 O/O gained
greater (14.4± 6.2 kg) or 188 who either lost or gained ≤5 kg (1.1± 4.4 kg). Birth weight, fat (FM)
and lean mass (LM) were assessed using anthropometry. Small for gestational age (SGA) was
defined as ≤ 10th percentile of a standard US population. Univariable and multivariable analysis
evaluated the association between weight change and neonatal morphometry.
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Results—There was no significant difference in age, race, smoking, parity, or gestational age
between groups. Weight loss or gain ≤ 5 kg was associated with SGA, 18/188 (9.6%) vs. 51/1053
(4.9%); (adjusted OR 2.6, 95% CI 1.4, 4.7; p=0.003). Neonates of women who lost or gained ≤ 5
kg had lower birth weight (3258 ± 443 g vs. 3467 ± 492g, p<0.0001), FM (403±175 vs. 471 ±
193g, p<0.0001), LM (2855±321 vs. 2995 ± 347g, p<0.0001) and smaller length, %FM and head
circumference (HC). Adjusting for diabetic status, pre-pregnancy BMI, smoking, parity, study site,
gestational age and gender; neonates of women who gained ≤ 5 kg had significantly lower birth
weight, LBM, FM, %FM, HC and length. There were no significant differences in neonatal
outcomes between those who lost weight and those who gained ≤ 5 kg.
Conclusion—In O/O weight loss or gain ≤ 5 kg is associated with increased risk of SGA and
decreased neonatal FM, LM and HC.
Keywords
fetal anthropometry; gestational diabetes; gestational weight loss
Introduction
The problem of obesity during pregnancy is now recognized as a major public health
concern.1 In the United States 55.8% of the female population 20–39 years of age is
overweight (BMI 25.0–29.9) or obese (BMI ≥ 30), based on World Health Organization
(WHO) body mass index criteria (BMI kg/m2).2 Because of the increase in obesity there has
been an increase in term mean birth weight in developed countries3,4 including the United
States.5 Although there are reports that the increase neonatal weight has reached a plateau or
decreased6 this may relate more to changes in population demographics such as ethnicity
and earlier gestational age at delivery.7 Being overweight or obese are significant problems
for women and their offspring during pregnancy. In early gestation there is a significant
increased risk of early spontaneous abortion and congenital malformations.8,9 In later
gestation there is a significant increased risk for the metabolic dysfunction associated with
insulin resistance presenting as gestational diabetes (GDM) and preeclampsia.10 At delivery
there is an increased risk for cesarean delivery, postpartum wound infection and deep vein
thrombophlebitis.11 For the neonate there is an increased risk of fetal macrosomia and more
specifically fetal adiposity.12 Increased adiposity at birth is associated with increased risks
of problems such as shoulder dystocia but may also be the harbinger of childhood obesity
and metabolic dysfunction.13
The Institutes of Medicine (IOM) in 2009 revised the gestational weight gain guidelines,
recommending that obese women should have a gestational weight gain of at least 5 kg
during pregnancy (5–9 kg), in order to at least meet the obligatory physiologic changes of
pregnancy.14 However some authors have recommended very limited, no weight gain, or
even weight loss during pregnancy in order to optimize pregnancy outcomes.15,16,17 Hence
the purpose of this research was to examine the effect of limited gestational weight gain or
weight loss during pregnancy on fetal weight, anthropometry and estimates of neonatal body
composition in overweight and obese women.
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This was a retrospective analysis of prospective multi-center data from 1241 singleton term
pregnancies in overweight and obese women examining the effect of limited gestational
weight gain or weight loss during pregnancy on fetal growth. The data included 890 patients
who were enrolled in the previously reported Eunice Kennedy Shriver National Institutes of
Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network
multicenter randomized trial of treatment of mild GDM.18 Three hundred and fifty-one
patients, who were enrolled in another ongoing study of GDM at MetroHealth Medical
Center evaluating neonatal growth at delivery, were also included in this analysis. Limited
gestational weight gain or loss during pregnancy was estimated as the documented weight at
the last prenatal visit minus self-recalled pre-pregnancy weight, and at MetroHealth, when
possible, confirmed by a first trimester weight at the first prenatal visit. Height was either
measured at the first prenatal visit using a stadiometer or obtained from the prenatal chart.
Subjects in this analysis included 395 women with a 50 g glucose challenge test (GCT) <
135 mg/dL, 418 women with a GCT ≥ 135 mg/dL but normal oral glucose tolerance test
(OGTT) defined as fasting less than 95 mg/dL, 1 hour < 180 mg/dL, 2 hour < 155 mg/dL
and 3 hour < 140 mg/dL, 255 with treated and 173 with untreated GDM (2 or more
abnormal values on the aforementioned OGTT). All subjects who required treatment in
addition to diet were treated with insulin. There were 36 in the MFMU cohort and 29 in the
MetroHealth cohort; total 65 or 5.2% of the 1241 subjects in the entire cohort.
All the subjects participating in the two studies provided written informed consent. The
study was approved by the human subjects committee at each of the participating MFMU
sites as well as the Institutional Review Board at MetroHealth Medical Center and the
Scientific Review Committee of the Clinical Research Unit of the CTSC at Case Western
Reserve University. Subjects enrolled in this analysis met the criteria for eligibility as
reported elsewhere in the primary report.18 Subjects were excluded if they met any of the
following conditions: an abnormal result on a glucose challenge test at < 24 weeks’
gestation or previous GDM; a history of stillbirth in a prior pregnancy, multi-fetal gestation,
asthma, or chronic hypertension, received corticosteroid therapy; or were carrying a fetus
thought to be anomalous. Similar inclusion and exclusion criteria were used for eligibility
for the MetroHealth subjects.
The primary outcome for this study was neonatal morphometry and body composition.
Small for gestational age (SGA) was defined as less than 10% for gestational age based on
birth weight percentiles from 1994–1996.19 Birth weight was measured on a calibrated scale
and length on a measuring board. Trained research staff performed the anthropometric
measures used to estimate neonatal body composition.20 The flank skinfold was measured in
the mid-axillary line just above the crest of the ilium. Skinfold measurement was made by
lifting the skin with the thumb and index finger with care not to include any underlying
tissue. Each skinfold was measured several times until a consistent and stable reading was
obtained. The circumference of the head was determined using a tape measure. The
coefficient of variation in the anthropometric measures is about 3% and 7% for the
skinfolds. Estimates of neonatal body composition were made using the previous validated
equation:
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. Lean body mass was calculated as birth weight minus fat mass and percent body fat as fat
mass/birth weight × 100. The correlation of this anthropometric model with air displacement
plethysmography (Pea Pod) estimates of neonatal fat and lean body mass (n=216) is: fat
mass (r = 0.83, p < 0.001) and lean body mass (r = 0.94, p < 0.0001) (unpublished data)
We compared baseline characteristics and neonatal outcomes by maternal gestational weight
gain less than or equal to 5 kg or greater than 5 kg. Student’s t-test and analysis of variance
tests were used for continuous variables and chi-square or Fisher’s exact test was used for
categorical variables. Multiple linear and logistic regression analysis was used to examine
the association of neonatal outcomes and weight gain less than or equal to 5 kg or greater
than 5 kg. adjusting for potential confounders. The models were adjusted for initial glucose
group (mild treated GDM, mild untreated GDM, normal OGTT, normal GCT), pre-
pregnancy BMI, smoking status, parity, study site, gestational age at delivery, and gender.
The interaction of initial glucose group and weight gain (≤ 5 kg vs. 5 kg or more) with each
of the neonatal outcomes was examined. Additional regression models examining weight
loss/gain classified as weight loss, gain ≤ 5 kg, gain > 5kg were also run. For these models,
the Tukey-Kramer method was used to adjust for multiple comparisons.21 Statistical
analyses were conducted with SAS software (SAS Institute, Cary, NC).
Results
Of the 1241 subjects in this cohort, 1053 (84.8%) had gestational weight gain greater than 5
kg and 188 (15.2%) had gestational weight gain less than 5 kg. Of 1053 women who gained
greater than 5 kg, 691 (65.6%) exceeded IOM gestational weight gain guidelines for their
respective pregravid BMI, 331 (31.4%) gained within IOM guidelines and 31 (2.9%) gained
below IOM guidelines. Of the women who gained less than 5 kg,139 (74.0%) were from the
MFMU study and 49 (26.1%) were from the MetroHealth study. Women who gained greater
than 5 kg had a mean (± SD) gestational weight gain of 14.4 ± 6.2 kg versus 1.1± 4.4 kg for
the women who gained ≤ 5 kg (p<0.0001). Demographic characteristics are shown in Table
1. Women who gained less than 5 kg during pregnancy had significantly greater pre-
pregnancy weight and BMI (p<0.0001). There was significant difference in the glucose
tolerance status in women who gained > 5 kg versus ≤ 5 kg (p=0.002). Women who gained
> 5 kg had a greater percentage of either a normal GCT or abnormal GCT and normal
OGTT, whereas women who gained ≤ 5 kg had a greater percentage of either treated GDM
or untreated GDM. There were no other significant differences in any other demographic
characteristic between groups.
Table 2 shows the neonatal characteristics of the women who gained less than and more than
5 kg. More neonates of women who gained ≤5 kg were SGA versus those whose mothers
gained > 5 kg (9.6% vs. 4.9%, p=0.009). More neonates of women who gained > 5 kg were
LGA versus those who gained ≤ 5 kg (13.2% vs. 7.5%, p=0.03). Relative to the
anthropometry, there was a significantly lower birth weight, length, lean mass, fat mass,
percent body fat and head circumference in the neonates of women who gained ≤ 5 kg in
contrast to those who gained more than 5 kg. When adjusted for status of glucose tolerance,
pre-pregnancy BMI, smoking, parity, study site (MFMU or MetroHealth), gestational age at
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delivery and gender, they remained significantly different. After adjustment for the same
variables, there remained a significant difference in SGA (adjusted OR 2.6, 95% CI 1.4, 4.7;
p=0.003). LGA was significantly decreased (adjusted OR 0.42. 95% CI 0.23, 0.77;
p=0.005). Further there was no significant interaction among the 4 study groups (mild
treated GDM, mild untreated GDM, normal OGTT, normal GCT) and weight change for
SGA or other outcomes.
Because some authors have suggested that weight loss during pregnancy in overweight and
obese women may improve pregnancy outcome, we further analyzed our data in the 46
(3.7%) of women who had a documented loss of weight (-5.0 ± 4.7 kg) versus the 1195
women who gained any weight (13.1 ± 6.9 kg) during pregnancy (p < 0.0001). Table 3
shows the neonatal characteristics of women who lost weight, gained 0 to 5 kg and gained
greater than 5 kg. There was a significant difference in birth weight, length, lean body mass,
fat mass and percent body fat and SGA among the groups. We next adjusted for glucose
status, group, prenatal BMI, smoking, parity, study site (MFMU or MetroHealth),
gestational age at delivery and male gender in the multiple regression analysis for the effect
of change in weight on the anthropometric outcomes making adjustments for multiple
comparisons (Table 3). There were significant differences between those who lost weight
and those who gained greater than 5 kg in each of the following; birth weight, lean body
mass, fat mass, percent body fat, head circumference and the proportion of SGA. There were
also significant differences between those who gained ≤ 5 kg and those who gained greater
than 5 kg in birth weight, lean body mass, fat mass, percent body fat and neonatal length. It
is important to note that a subject’s glucose status did not affect SGA results. In women with
GDM, whether treated or untreated, there was no significant difference in the risk of SGA in
women who lost weight or gained less than 5 kg as compared with women who gained > 5
kg (adjusted OR 1.5, 95% CI 0.5, 4.4; p=0.43). Additionally when we eliminated all the
GDM subjects, the results for the non-GDM cohort show that this group is similar to the
entire cohort (data not shown).
Comment
Overweight and obese women who lose weight or gain less than 5 kg weight during
pregnancy have neonates who in addition to an increase in SGA have a significant decrease
in lean body mass and fat mass as compared with overweight and obese women who gain
greater than 5 kg weight during pregnancy. Some authors have criticized the IOM
gestational weight gain recommendations for being too conservative for overweight and
obese women and suggested that less gestational weight gain, no weight gain or even weight
loss might be more appropriate for this population.15,16,17 We observed that weight gain ≤5
kg in these women was associated with a significantly lower birth weight, lean body mass,
fat mass, percent body fat and length as compared with the neonates of overweight and
obese women who gained greater than 5 kg. In these women the potential long term
consequences for the offspring of this difference in lean body mass (i.e., decreases in head
circumference and length) is unclear but could be associated with further increased
metabolic and cognitive risk for the offspring.22 We elected to use the 5 kg weight cutoff for
both overweight and obese since our objective was to to evaluate inadequate gestational
weight gain and fetal growth among overweight and obese women and not base the study
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objective on strict IOM criteria. Many clinicians may consider weight gain between 5–7 kg
in overweight women as adequate. Hence we elected to choose the lower limit of gestational
weight gain at 5 kg rather than using a separate lower limit of gestational weight gain for
overweight and obese women.
The results of our study agree with those of Beyerlein et al, who reported that gestational
weight loss in overweight and obese class I and II women was associated with an increase in
SGA.23 However, these authors found no increase in SGA in women in class III obesity,
which were highly represented in our study cohort. The results of our study differ from
recent reports from two Scandinavian groups. Asbjornsdottir et al in a small study evaluated
fetal growth in 58 Danish women with type 2 diabetes who were advised to gain 0–5 kg
weight during pregnancy.24 Seventeen women (29%) gained less than 5 kg and the
remaining 41 gained greater than 5 kg. There was no significant difference in SGA neonates
3 (18%) vs. 4 (10%), p=0.41, but there was a significant decrease in birth weight Z score,
-0.44 (-3.31 to 1.98) vs. 0.84 (-2.32 to 4.02), p=0.008). The authors concluded that in obese
women with type 2 diabetes, maternal gestational weight gain less than 5 kg was associated
with a more proportionate birth weight and less perinatal morbidity. The differences in
results may relate to differences in sample size, type 2 vs. GDM, and ethnicity of the study
populations. Bloomberg25 using a Swedish birth cohort reported that women with class II
and III obesity who lost weight had an increased risk for SGA which was no longer
significant with low weight gain in class III obese women, but persisted in those with class
II obesity.
The strength of our study is that in addition to classification of fetal growth using birth
weight and characterization of birth weight percentiles for SGA, we were able to measure
neonatal anthropometrics and estimate neonatal body composition. All of the measurements
were performed using the same standard protocol at each study location. The limitations of
our study is that although the data were collected prospectively this was a retrospective
analysis. We also used self-reported pre-pregnancy weight and in some patients confirmed
with a first trimester weight at the first antenatal visit. As in most other studies reliable pre-
pregnancy weight was not readily available. Another limitation of our study is that there
were a small number of subjects who lost weight during gestation and we were not able to
adjust for all potential confounding variables.
What are the potential mechanisms associated with a decrease in lean body mass as well as
fat mass in neonates of overweight and obese women who lose weight during pregnancy?
Weight loss in overweight and obese non-pregnant individuals includes both loss of fat mass
and lean body mass. A 10 kg weight loss by diet alone would be expected to have a decrease
in lean body mass of between 2–3 kg.26 During pregnancy it is very likely that maternal
weight loss is associated with a loss of maternal lean body mass as well as fat mass.
The obligatory physiologic weight gain during pregnancy accounts for approximately 8 kg
of water and 1 kg of protein plus variable amounts (1–6 kg) of adipose tissue.14 Since the
average weight loss in women who lost weight was -5 kg, plus the obligatory physiologic
weight change in pregnancy is approximately 9 kg, this means that the estimated maternal
tissue weight loss was on the average of 14 kg or 31 lbs. This decrease of 14 kg most likely
Catalano et al. Page 6






















represents loss of both maternal lean body mass and fat mass, particularly since only
vigorous exercise during weight loss has been shown to spare considerable loss of lean body
mass.27 Vigorous exercise was unlikely in these overweight and obese pregnant women.
Hence, we speculate that in overweight and obese women who lose weight during gestation
that there is the adaptive protective mechanism to retain lean body mass as well as lose fat
mass, thereby decreasing protein availability for fetal growth. This then would result in
disproportionate decrease in fetal lean body mass relative to fat mass. Only prospective
longitudinal metabolic studies will definitively address and answer these questions.
What are the implications for the neonate because of these significant decreases in lean body
mass and fat mass in overweight and obese women who lose weight or gain < 5 kg during
pregnancy? While increased body fat is a risk for childhood obesity, the addition of a
decrease in lean body mass (including length and head circumference) further increase
metabolic and cognitive risk for the offspring.22 The decrease in lean body mass in these
neonates may be a forme fruste of metabolic stunting observed in children in developing
countries, where there is a dearth of quality protein. The WHO defines stunting as length
less than 2 standard deviations below the WHO Multicentre Growth Reference Study Group,
2006.28 However, many children are not classified as stunted until age 2 or 3 because the
continuation of poor nutrition in early life, i.e. the first 1000 days of perinatal programming.
A decrease in lean body mass in the offspring may increase the risk of metabolic
dysfunction in later life because of the decreased ability to store ectopic fat in tissues such as
skeletal muscle and liver. The ectopic fat may act as an additional source of inflammation
increasing insulin resistance.29 Because the women in this study who lost weight during
pregnancy were primarily class III, the poor nutrition in utero the fetus was exposed to may
persist in early childhood, despite a surfeit of poor quality of nutritional calories.
In conclusion, weight loss or weight gain less than 5 kg in overweight and obese women
during pregnancy increases the risk of SGA, decreases in fat mass and of potentially greater
significance, decreases in lean body mass including length and head circumference as
compared with those infants whose mothers had a gestational weight gain of greater than 5
kg. These preliminary findings need to be confirmed in prospective studies using more
sophisticated methodologies to assess maternal nutrient metabolism and fetal growth.
Information concerning the amount and type of energy intake and expenditure available will
help determine if the weight loss is a result of decreased intake or increased energy
expenditure. If inadequate intake is the primary issue, information on maternal protein
metabolism may be critical because of the effect on lean body mass in the fetus. Other
factors such as when in gestation the inadequate weight gain occurred may offer insights
into the pathophysiology of the changes in body composition of the fetus.
In the interim, although the American Congress of Obstetricians and Gynecologists in a
recent Committee Opinion recommends that for the overweight or obese woman who is
gaining or wishes to gain less weight than recommended by the IOM care be individualized
based on the appropriate growth of the fetus, we urge caution.30 A far safer alternative
would be, as women’s health care physicians, to recommend a lifestyle approach of
attainment of normal body weight through diet and exercise postpartum for all overweight or
obese women. This approach may be of specific benefit for those overweight and obese
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woman planning another pregnancy as weight loss between pregnancies has been shown to
decrease adverse pregnancy outcomes in a subsequent pregnancy.31
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• Inadequate gestational weight gain in overweight and obese women increases
the risk of their having infants that are small for gestational age and alterations
in fetal composition.
• The long-term implications of inadequate weight gain in infants of overweight
and obese women are uncertain and require further examination.
• Ideally, weight reduction in overweight and obese women should occur before a
planned pregnancy.
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Table 1
Maternal Characteristics
Gestational Weight loss or gain ≤ 5 kg (n = 188) Gestational Weight gain > 5 kg (n = 1053) p-value
Age (years) 28.2 ± 5.7 28.1 ± 5.8 0.67
Pre-pregnancy height (cm) 159.3 ± 8.2 160.1 ± 7.5 0.19
Pre-pregnancy weight (kg) 87.4 ± 21.9 78.2 ± 16.1 <0.0001
Pre-pregnancy BMI (kg/m2) 34.2 ± 7.1 30.4 ± 5.2 <0.0001
 25.0 – <30 59 (31.4) 627 (59.5)
 30.0 – ≤40 97 (51.6) 370 (35.1)
 > 40 32 (17.0) 56 (5.3)
Tobacco use + (%) 29 (15.4) 120 (11.4) 0.12
Parity (%) 0.09
 1 30 (16.0) 231 (21.9)
 2 68 (36.2) 396 (37.6)
 3+ 90 (47.9) 426 (40.5)
Race (%) 0.99
 White 62 (33.0%) 345 (32.8%)
 AA/Black 38 (20.2%) 220 (20.9%)
 Hispanic 85 (45.2%) 469 (44.5%)
 Other 3 (1.6%) 19 (1.8%)
Glucose status (%) 0.002
 Normal GCT 52 (27.7%) 343 (32.6%)
 Abnl GCT/NL OGTT 52 (27.7%) 366 (34.8%)
 GDM treated 58 (30.9%) 197 (18.7%)
 GDM untreated 26 (13.8%) 147 (14.0%)
Weight gain/loss (kg) 1.1 ± 4.4 14.4 ± 6.2 < 0.0001
Data are presented as mean ± SD. Percents are in (%).
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Table 2
Neonatal Characteristics
Gestational Weight loss or gain ≤ 5 kg (n = 188) Gestational Weight gain > 5 kg (n = 1053) p-value
Gestational age (weeks) 38.8 ± 1.4 38.9 ± 1.4 0.28
Gender (%) 0.32
 Male 89 (47.3) 540 (51.3)
 Female 99 (52.7) 540 (51.3)
Birth weight (g) 3258.4± 442.7 3466.8 ± 491.5 <0.0001
Length (cm) 49.3 ± 2.3 50.0 ± 2.8 0.001
Head circumference (cm) 34.2 ± 1.7 34.5 ± 1.7 0.02
Lean Mass (g) 2855.1 ± 321.0 2995.4 ± 346.9 <0.0001
Fat mass (g) 403.4 ± 175.3 471.4 ± 192.7 <0.0001
Body fat (%) 12,0 ± 4.2 13.2 ± 4.3 0.0006
LGA 14 (7.5%) 139 (13.2%) 0.03
SGA 18 (9.6%) 51 (4.9) 0.009
Data are presented as mean ± SD. Percents are in (%).
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